ImmunityBio, Inc.'s recent progress on Anktiva and rBCG, including FDA submissions and collaborations, positions the company for significant revenue growth despite current financial challenges. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback